PGC emerged from its Q2 print with the Street's conviction intact — and one analyst wasted no time raising the bar.
Piper Sandler moved its target to $58 on July 29, up from $54, maintaining its Overweight rating. That follows Raymond James's lift to $55 in early July and Piper's own prior raise to $54 in late June. The pattern is consistent: every analyst action in 2026 has been a target increase, never a cut. The consensus mean now stands at $53.94, roughly 13% above the current price of $47.72. For a New Jersey community bank, that gap is unusually wide and reflects a Street view that the stock's near-flat one-month performance — down less than 1% — understates the fundamental improvement underway. EPS momentum ranks in the 86th to 87th percentile over both 30- and 90-day windows, and the company scores in the 86th percentile on EPS surprise consistency.
The bull case centers on loan growth and net interest income expansion. NII rose 37.8% year-over-year in the most recent reported quarter, driven by 9% loan growth and a 52 basis-point widening in net interest margin to 2.77%. Bears point to elevated expenses tied to the NYC metro franchise build-out and higher provision costs, which contributed to an earnings miss that briefly sent the stock down nearly 9% earlier in the cycle. Asset quality remains an overhang. The Q2 reaction, however, was constructive: the stock gained roughly 2.9% on the day following the July 27 print and added another 1.4% on July 28, suggesting the market viewed the result as a clearing event rather than a new concern.
Positioning in the lending market gives short sellers no particular advantage here. Short interest sits at 3.7% of the free float — elevated enough to note but not at a level that creates pressure. More telling is the borrow environment: availability is extraordinarily loose at nearly 2,000% of short interest, meaning there are roughly 20 shares available to lend for every one currently borrowed. Borrowing costs are negligible at 0.51%. The ORTEX short score has drifted lower through the past two weeks, from 40.2 on July 15 to 39.2 now, placing PGC in the 28th percentile of short pressure. None of this points to a short thesis gathering momentum. Options are similarly benign — the put/call ratio of 0.22 runs slightly above its 20-day average of 0.18 but only by about one standard deviation, with the stock running at a P/E of 10.9x and a price-to-book of 1.06x.
Institutional ownership rounds out the picture. BlackRock added 41,000 shares in the June quarter, State Street added 43,000, and American Century added 75,000 — three independent passive and active managers all moving in the same direction. Boston Partners added nearly 88,000 shares. The insider picture is more nuanced: the CFO and CEO made significant open-market purchases at around $35 in late March, picking up roughly $500,000 worth of stock near what proved to be a trough. More recent insider activity has flipped to modest selling — an EVP and a division president sold a combined $288,000 in late June — but those transactions carry low significance scores and are consistent with routine liquidity rather than a directional view. The 90-day net insider position remains positive at roughly 13,500 shares.
The next scheduled earnings date is October 23. Between now and then, the story will likely hinge on whether net interest margin continues to expand and whether the NYC build-out costs begin to moderate — two variables the Street is clearly watching closely enough to keep raising targets into every print.
See the live data behind this article on ORTEX.
Open PGC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
